Financials
- Market Capitalization 678.23 M
- Employee 113
- Founded 2009
- CEO N/A
- Website www.aurabiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00226DGM5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.1
Relación precio/flujo de caja
49.59
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2629 | MDXG MiMedx Group, Inc - Common Stock | 4.83 USD | +3.43% | +5.23% | +6.39% | -25.23% | 704.02 M USD | ||
| 2650 | DSGN Design Therapeutics, Inc. - Common Stock | 10.91 USD | -6.35% | -12.79% | -25.83% | +72.08% | 682.77 M USD | ||
| 2659 | PHAR Pharming Group N.V. - ADS, each representing 10 | 9.61 USD | -1.84% | -2.54% | -10.85% | -34.40% | 674.31 M USD | ||
| 2661 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.32 USD | -0.61% | +6.49% | -5.90% | +6.39% | 672.22 M USD |